NATERA, INC. Accounts Receivable, Allowance for Credit Loss
NATERA, INC. (NTRA) had Accounts Receivable, Allowance for Credit Loss of $8.02 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Assets
us-gaap:AllowanceForDoubtfulAccountsReceivable · last filed 2026-02-27
- 2025-12-31: Accounts Receivable, Allowance for Credit Loss $8.02M.
- 2024-12-31: Accounts Receivable, Allowance for Credit Loss $7.26M.
- 2023-12-31: Accounts Receivable, Allowance for Credit Loss $6.48M.
- 2023-03-31: Accounts Receivable, Allowance for Credit Loss $1.30M.
| Period end | Accounts Receivable, Allowance for Credit Loss | Accounts Receivable, Allowance for Credit Loss as first filed |
|---|---|---|
| 2025-12-31 | $8.02M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $7.26M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $6.48M 10-K · filed 2026-02-27 | |
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-10 | |
| 2022-12-31 | $3.83M 10-K · filed 2026-02-27 | |
| 2021-12-31 | $2.43M 10-K · filed 2025-02-28 | |
| 2021-09-30 | $4.11M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $3.79M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $4.11M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $4.22M 10-K · filed 2024-02-29 | |
| 2020-09-30 | $4.31M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $4.31M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $4.30M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.92M 10-K · filed 2023-03-01 | $3.30M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $1.79M 10-K · filed 2022-02-25 | |
| 2017-12-31 | $2.00M 10-K · filed 2021-02-26 | |
| 2016-09-30 | $1.32M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.21M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $1.20M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $971.00K 10-Q · filed 2016-11-14 | |
| 2015-09-30 | $784.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $628.00K 10-Q · filed 2015-08-13 | |
| 2014-12-31 | $527.00K 10-K · filed 2016-03-24 | |
| 2013-12-31 | $508.00K 10-K · filed 2016-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |